Table 1. Correlation between the factors and clinicopathologic characteristics in HCC (n=157).
| Clinicopathological indexes | Lncrna00364 | ||
|---|---|---|---|
| Low | High | P | |
| Age(year) | 26 | 28 | 0.411 |
| ≤50 | 53 | 50 | |
| >50 | |||
| Sex | 9 | 16 | 0.132 |
| Female | 70 | 62 | |
| Male | |||
| HBsAg | 6 | 9 | 0.285 |
| Negative | 69 | 73 | |
| Positive | |||
| HBcAb | 44 | 38 | 0.237 |
| Negative | 35 | 40 | |
| Positive | |||
| HBeAg | 75 | 61 | 0.002 |
| Negative | 4 | 17 | |
| Positive | |||
| HBV-DNA | 50 | 49 | 0.541 |
| Negative | 29 | 29 | |
| Positive | |||
| HCV | 76 | 76 | 0.506* |
| Negative | 3 | 2 | |
| positive | |||
| AFP (ng/ml) | 47 | 41 | 0.238 |
| ≤20 | 32 | 37 | |
| >20 | |||
| TB(umol/L) | 73 | 67 | 0.146 |
| ≤20 | 6 | 11 | |
| >20 | |||
| ALT(U/L) | 67 | 63 | 0.323 |
| ≤50 | 12 | 15 | |
| >50 | |||
| PALB(g/L) | 20 | 21 | 0.481 |
| ≤0.25 | 59 | 57 | |
| >0.25 | |||
| ALB(g/L) | 27 | 17 | 0.06 |
| ≤35 | 52 | 61 | |
| >35 | |||
| GGT (U/L) | 57 | 54 | 0.410 |
| ≤60\ | 22 | 24 | |
| >60 | 22 | 24 | |
| PT(s) | 60 | 66 | 0.122 |
| ≤13 | 19 | 12 | |
| >13 | |||
| AKP(U/L) | 65 | 67 | 0.344 |
| ≤125 | 14 | 11 | |
| >125 | |||
| Liver cirrhosis | 31 | 39 | 0.116 |
| No | 48 | 39 | |
| Yes | |||
| Tumor size(cm) | 26 | 45 | 0.001 |
| ≤5 | 53 | 33 | |
| >5 | |||
| Tumor number | 62 | 64 | 0.359 |
| Single | 17 | 14 | |
| Multiple | |||
| Microvascular invasion | 29 | 27 | 0.457 |
| Absence | 50 | 51 | |
| Present | |||
| Tumor encapsulation | 43 | 55 | 0.027 |
| Complete | 36 | 23 | |
| None | |||
| Tumor differentiation | 41 | 43 | 0.403 |
| I+II | 38 | 35 | |
| III+IV | |||
| TNM stage | 27 | 33 | 0.188 |
| I | 52 | 45 | |
| II+III | |||
AFP, alpha-fetoprotein; GGT, gamma glutamyl transferase; TNM, tumor-node-metastasis; ALT, alanine transaminase;
TB, total bilirubin; PALB, prealbumin; ALB, albumin; AKP, alkaline phosphatase;
*Fisher's exact tests; chi-square tests for all other analyses.